Risk factors for cardiovascular disease in children on chronic hemodialysis – Traditional (general) risk factors, Part I

Ljiljana S Šulović

doi:10.2298/VSP150418133S

Ljiljana S Šulović Department of Cardiology, Children's Hospital, Faculty of Medicine, University Priština-Kosovska Mitrovica, Kosovska Mitrovica, Serbia

DOI: https://doi.org/10.2298/VSP150418133S

Keywords: renal insufficiency, chronic, child Abuse, cardiovascular diseases, risk factors, hypertension, dyslipidemias, atherosclerosis, obesity,

References

Chavers BM, Solid CA, Daniels FX, Chen S, Collins AJ, Frankenfield DL, et al. Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol 2009; 4(8): 1363−9.

Flynn JF. Hypertension in the young: epidemiology, sequelae, therapy. Nephrol Dial Transplant 2009; 24: 370−5.

VanDeVoorde RG, Barletta GM, Chand DH, Dresner IG, Lane J, Leiser J, et al. Blood pressure control in pediatric hemodialysis: The Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol 2007; 22(4): 547−53.

Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 2012; 23(4): 578−85.

Šulović LJ, Šulović N. The role of echocardiography measure-ment index collapsing VCI in the evaluation of dialysis and determining the state of hydration. Praxis medica 2016; 45(2). (In press)

Šulović LJ. Cardiovascular complications in children on chronic hemodialysis. 1st ed. Niš: M COPS CENTAR; 2013. (Serbian)

Šulović LJ. Non-invasive assessment of cardiac function in children on chronic hemodialysis.[dissertation] Kosovska Mi-trovica: School of Medicine; 2008. (Serbian)

Tkaczyk M, Nowicki M, Bałasz-Chmielewska I, Boguszewska-Baçzkowska H, Drozdz D, Kołłataj B, et al. Hypertension in dia-lysed children: The prevalence and therapeutic approach in Poland: A nationwide survey. Nephrol Dial Transplant 2006; 21(3): 736−42.

Šulović LJ. Is hypertension, in children who are on chronic he-modialysis therapy, crucial for the development of cardiac hy-pertrophy. Praxis medica 2016; 44(1): 15–7. (Serbian)

Halbach SM, Martz K, Mattoo T, Flynn J. Predictors of blood pressure and its control in pediatric patients receiving dialysis. J Pediatr 2012; 160(4): 621−5.

Hölttä T, Happonen JM, Rönnholm K, Fyhrquist F, Holmberg C. Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol 2001; 16(4): 324−31.

Lingens N, Soergel M, Loirat C, Busch C, Lemmer B, Schärer K. Ambulatory blood pressure monitoring in paediatric patients treated by regular haemodialysis and peritoneal dialysis. Pediatr Nephrol 1995; 9(2): 167−72.

Lerner GR, Warady BA, Sullivan EK, Alexander SR. Chronic di-alysis in children and adolescents: The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr. Nephrol 1999; 13(5): 404−17.

Krmar RT, Berg UB. Blood pressure control in hypertensive pe-diatric renal transplants: Role of repeated ABPM following transplantation. Am J Hypertens 2008; 21(10): 1093−9.

Candan C, Sever L, Civilibal M, Caliskan S, Arisoy N. Blood vol-ume monitoring to adjust dry weight in hypertensive pediatric hemodialysis patients. Pediatr Nephrol 2009; 24(3): 581−7.

Patel HP, Goldstein SL, Mahan JD, Smith B, Fried CB, Currier H, et al. A standard, noninvasive monitoring of hematocrit algo-rithm improves blood pressure control in pediatric hemodialy-sis patients. Clin J Am Soc Nephrol 2007; 2(2): 252−7.

Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, et al. Masked hypertension associates with left ventricular hy-pertrophy in children with CKD. J Am Soc Nephrol 2010; 21(1): 137−44.

Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, et al. Dyslipidemia in children with chronic kidney disease. Kidney Int 2010; 78(11): 1154−63.

Saland JM, Ginsberg HN. Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 2007; 22(8): 1095−112.

North American Pediatric Renal Trials and Collaborative Stud-ies. Annual Dialysis Report. 2011. Available from: https://web.emmes.com/.../annualrept2011

Daniels SR, Greer FR. The Committee on Nutrition. Lipid Screening and Cardiovascular Health in Childhood. Pediatrics 2008; 122(1): 198−208.

Kidney Disease Outcomes Quality Initiative (K/DOQI) Group. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003; 41(4 Suppl 3):I-IV, S1-91.

Wiesbauer F, Heinze G, Mitterbauer C, Harnoncourt F, Hörl WH, Oberbauer R. Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol 2008; 19(11): 2211−8.

Serón D, Oppenheimer F, Pallardó LM, Lauzurica R, Errasti P, Gomez-Huertas E, et al. Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial. Transplantation 2008; 86(1): 82−7.

Baigent C, Landry M. Study of Heart and Renal Protection (SHARP). Kidney Int Suppl 2003; (84): S207−10.

Fellström B, Holdaas H, Jardine AG, Rose H, Schmieder R, Wilpshaar W, et al. Effect of rosuvastatin on outcomes in chronic haemodialysis patients: Baseline data from the AURORA study. Kidney Blood Press Res 2007; 30(5): 314−22.

KDOQI Work Group. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update. Executive summary. Am J Kidney Dis 2009; 53(3 Suppl 2): S11−104.

Civilibal M, Caliskan S, Kurugoglu S, Candan C, Canpolat N, Sever L, et al. Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol 2009; 24(3): 555−63.

Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, et al. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 2008; 23(8): 2552−7.

Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 2008; 23(10): 3263−71.

Nayir A, Bilge I, Kiliçaslan I, Ander H, Emre S, Sirin A. Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 2001; 16(10): 2041−7.

Hanevold CD, Ho P, Talley L, Mitsnefes MM. Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2005; 115(2): 352−6.

Canpolat N, Caliskan S, Sever L, Guzeltas A, Kantarci F, Candan C, et al. Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease. Pediatr Nephrol 2012; 27(4): 627−35.

US Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kid-ney Diseases; 2012.

Dunjic M, Jevremovic M, Sulovic LJ, Stanisic M, Dunjic S, Dunjic B, et. al. Early diagnosis of non-insulin dependent diabetes mellitus made by Bi-Digital O-Ring Test (BDORT). Acupunct Electro-Therapeut Res 2003; 28(1−2): 96−9.

Painter P, Krasnoff J, Mathias R. Exercise capacity and physical fitness in pediatric dialysis and kidney transplant patients. Pe-diatr Nephrol 2007; 22(7): 1030−9.

Weaver DJ, Kimball TR, Knilans T, Mays W, Knecht SK, Gerdes YM, et al. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol 2008; 19(3): 624−30.